00:19 , Jun 24, 2016 |  BC Extra  |  Financial News

Annexon raises $44M in B round

Annexon Biosciences Inc. (South San Francisco, Calif.) raised $44 million in a series B round led by new investor New Enterprise Associates. New investor Correlation Ventures also participated, as did existing investors including Novartis Venture...
07:00 , Jun 15, 2015 |  BioCentury  |  Finance

Products, hold the platform

While many VCs are pumping record-breaking amounts of capital into big idea platform companies and urging them to fully explore their technologies, Clarus Ventures is sticking with its more measured approach. In addition to...
08:00 , Dec 22, 2014 |  BioCentury  |  Finance

Annexon connections

Novartis Venture Fund recruited a syndicate to back Annexon Bioscience's complement modulating approach to target a key step in neurodegeneration arising from different causes. Those efforts yielded last week's $34 million series A-1 round, led...
03:17 , Dec 16, 2014 |  BC Extra  |  Financial News

Annexon raises $34M in series A-1

Annexon Bioscience raised $34 million in a series A-1 round led by Novartis Venture Fund along with Satter Investment Management and Clarus Ventures. All were new investors. CEO Doug Love told BioCentury the round is...